Topics

Endocrine Society updates osteoporosis Clinical Practice Guideline

19:00 EST 17 Feb 2020 | AAAS

(The Endocrine Society) The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture.

Original Article: Endocrine Society updates osteoporosis Clinical Practice Guideline

NEXT ARTICLE

More From BioPortfolio on "Endocrine Society updates osteoporosis Clinical Practice Guideline"

Quick Search

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Endocrinology
Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...